CareDx, Inc. v. Eurofins Viracor, Inc.

  1. December 02, 2022

    Fed. Circ. Won't Rethink Axed Stanford Kidney Test Patents

    The Federal Circuit on Friday declined to review en banc a panel's decision that three Stanford University diagnostic patents licensed to a developer of commercial tests for kidney transplant rejections are ineligible for protection.

  2. July 18, 2022

    Federal Circuit Upholds Invalidation Of Kidney Test Patents

    The Federal Circuit on Monday refused to undo a lower court's finding that three Stanford University patents licensed to a developer of commercial tests for kidney transplant rejections were invalid, saying they are directed toward natural phenomena.